HRS23 Announces Late-breaking Clinical Trials and Science Sessions
Heart Rhythm 2023, the society's 44th annual meeting, takes place May 19-21, in New Orleans
Source: dicardiology.com
Page 6 - Evaluate Safety News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Evaluate Safety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Evaluate Safety Today - Breaking & Trending Today
SynerFuse™ Announces IDE Proof of Concept Study Data Presented at Minnesota Neuromodulation Symposium
/PRNewswire/ -- Justin Zenanko, CEO of SynerFuse™, is proud to announce that Michael Park, M.D., associate professor of neurosurgery at the University of...
Source: prnewswire.com
You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and notes thereto for the... | March 27, 2023
Source: marketscreener.com
Alligator Bioscience & Aptevo Therapeutics Announce Dosing of First Patient with ALG.APV-527 in Phase 1 Clinical Trial
Trial to Evaluate Safety, Tolerability and Clinical Activity in Solid Tumors Expressing 5T4LUND, SWEDEN and SEATTLE, WA / ACCESSWIRE / February 13, 2023 / Alligator Bioscience AB ("Alligator") (Nasdaq
Source: finanznachrichten.de
SynerFuse™ Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study
/PRNewswire/ -- Justin Zenanko, CEO of SynerFuse, Inc., a Minnesota-based medical device company, is pleased to announce that for the first time in the world,...
Source: prnewswire.com